Replies to post #394007 on NorthWest Biotherapeutics Inc (NWBO)

[marzan]

what a blessing for the success of DcVaxL trial that came from WHO via its GBM Re-definition - very favorable to NWBO as DcVaxL works real well for IDH wild type GBMs. We should already be trading Judge/Sojo's $7 cloud highs. Go NWBO!

[HappyLibrarian]

Wouldn’t the redefinition of GBM reduce the potential market for DCVax-L? Maybe the purported increase in the chances of approval for that smaller market are worth it but no one seems to notice the inevitable trade off here.